Biogen Inc. Financial Ratios — IDP.DE Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	49.58	36.35	34.37	37.55	33.01	27.15	16.44	27.63	36	26.29	11.16	20.06	6.81	8.85	6.49
Return on Assets (%)	14.4	14.39	16.94	22.42	20.98	17.47	10.91	18.11	22.42	15.43	6.42	12.58	4.52	5.95	4.5
Return on Capital (%)	33.6	28.71	30	35.08	24.98	19.37	11.72	20.67	26.87	18.47	7.52	14.94	5.75	7.26	5.72
Return on Invested Capital (%)	18.61	17.59	21.54	28	27.41	24.22	15.36	24.18	30.37	18.59	14.57	12.26	7.76	8.44	8.4
Gross Margin (%)	90.75	90.11	87.63	87.93	88.48	87.08	86.72	86.5	86.4	86.57	80.79	77.61	74.24	76.12	75.69
EBITDA Margin (%)	42.36	39.96	43.59	47.46	52.17	55.35	53.86	49.44	52.17	36.47	30.01	33.62	23.82	30.53	32.85
Operating Margin (%)	35.25	33.33	35.92	40.37	46.59	49.39	45.05	44.61	48.93	33.07	25.57	28.52	18.79	23.57	24.96
Incremental Operating Margin (%)	63.44	12.55	46.02	51.49	103.55	93.36	-15.15	39.98	111.88	277.45	66.52	-11.62	312.08	-270.95	87.84
Pretax Margin (%)	33.89	33.63	35.78	40.67	44.29	43.09	41.79	43.85	49.56	37.54	15.89	35.31	13.18	19.7	15.74
Profit Margin (%)	24.45	25.02	26.86	30.25	32.95	32.34	20.69	32.93	40.96	29.76	14.17	29.95	11.81	16.87	13.07
Net Income to Common Margin (%)	24.45	25.02	26.86	30.25	32.95	32.34	20.69	32.93	40.96	29.76	14.17	29.95	11.81	16.87	13.07
Effective Tax Rate (%)	25.98	25.37	24.23	25.08	24.37	25.08	47.94	24.16	16.25	19.66	3.01	17.62	10.43	14.37	16.94
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	49.58	36.35	34.37	37.55	33.01	27.15	16.44	27.63	36	26.29	11.16	20.06	6.81	8.85	6.49

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1,064	1,141	596	583	6,526	6,517	5,938	5,936	6,368	7,828	7,604	6,614	7,338	6,630	6,577
ST Debt	3	453	3	3	5	5	3	- -	1,496	- -	999	- -	150	1,749	- -
LT Debt	1,061	687	592	580	6,522	6,513	5,935	5,936	4,872	7,828	6,604	6,614	7,188	4,882	6,577
Total Debt/EBITDA	0.5	0.52	0.2	0.13	1.16	1.03	0.9	0.89	0.85	1.6	2.31	1.93	3.13	2.24	2.02
Net Debt/EBITDA	0.26	0.26	- -	-0.13	0.93	0.66	0.66	0.71	0.41	1.24	1.52	0.84	2.51	1.33	1.01
Total Debt/EBIT	0.6	0.62	0.24	0.15	1.3	1.15	1.07	0.99	0.91	1.76	2.71	2.28	3.97	2.91	2.66
Net Debt/EBIT	0.31	0.31	- -	-0.16	1.04	0.74	0.79	0.79	0.43	1.37	1.78	0.99	3.19	1.72	1.33
EBITDA to Interest Expense	64.81	60.39	94.72	156.1	58.8	24.37	26.36	33.16	40.02	22.04	13	13.87	9.49	11.8	12.15
EBITDA-CapEx/Interest Expense	58.51	53.41	-15.28	145.39	51.9	21.57	18.53	28.74	36.45	19.56	11.83	12.88	8.23	10.36	11.27
EBIT to Interest Expense	53.93	50.37	78.06	132.77	52.51	21.75	22.05	29.91	37.54	19.98	11.07	11.77	7.48	9.11	9.23
Interest Expense	33	36	32	30	96	260	251	201	187	222	254	247	247	250	268
Common Equity/Total Assets	34.33	44.29	53.52	64.86	62.59	65.88	66.84	64.29	60.42	56.77	58.26	67.06	65.67	68.66	69.81
Long-Term Debt/Equity (%)	16.51	9.87	6.87	5.37	69.56	53.7	47.11	45.55	36.52	73.26	60.26	49.4	48.57	29.2	36.03
Long-Term Debt/Capital (%)	25.42	12.21	8.53	5.88	34.81	30.18	27.31	26.76	21.35	35.92	30.61	28.67	28.79	18.86	24.24
Long-Term Debt/Total Assets (%)	11.72	6.79	4.99	4.05	33.44	28.47	25.09	23.47	17.89	31.8	27.66	26.94	26.78	17.4	22.34
Total Debt/Equity (%)	16.56	16.38	6.91	5.39	69.61	53.74	47.14	45.55	47.74	73.26	69.38	49.4	49.58	39.66	36.03
Total Debt/Capital (%)	25.5	20.26	8.58	5.91	34.83	30.2	27.32	26.76	27.9	35.92	35.24	28.67	29.39	25.61	24.24
Total Debt/Total Assets (%)	11.76	11.26	5.02	4.08	33.46	28.49	25.11	23.47	23.38	31.8	31.84	26.94	27.34	23.64	22.34
Net Debt to Equity	8.55	8.19	-0.08	-5.75	55.66	34.55	34.64	36.16	22.8	57.04	45.73	21.37	39.79	23.46	17.96
Net Debt/Capital (%)	15.02	11.27	-0.11	-7.17	29.94	21.77	21.65	22.48	15.28	29.79	25.94	14.56	24.62	16.67	13.59
EBITDA	2,139	2,204	3,022	4,605	5,615	6,337	6,610	6,651	7,500	4,904	3,296	3,420	2,342	2,954	3,249
EBITDA-CapEx	1,931	1,950	-487	4,289	4,957	5,609	4,648	5,765	6,831	4,352	3,001	3,177	2,031	2,594	3,014
Operating Income (Loss)	1,780	1,838	2,490	3,917	5,015	5,654	5,529	6,001	7,036	4,446	2,808	2,902	1,848	2,280	2,469

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.85	1.03	0.7	0.83	1.33	1.43	1.1	1.07	0.92	0.7	0.88	1.49	0.31	0.43	1.14
Current Ratio	3.26	1.96	1.81	2.04	2.6	2.55	2.34	2.32	1.72	1.84	1.83	2.99	2	1.35	2.68
Quick Ratio	2.74	1.61	1.31	1.54	1.93	1.94	1.78	1.83	1.43	1.32	1.34	2.15	0.92	0.77	1.7
CFO/Avg Current Liab	1.76	1.46	1.37	1.48	1.63	1.53	1.34	1.86	1.74	0.98	0.91	0.37	0.46	0.64	0.5
Common Equity/Total Assets	34.33	44.29	53.52	64.86	62.59	65.88	66.84	64.29	60.42	56.77	58.26	67.06	65.67	68.66	69.81
Long-Term Debt/Equity (%)	16.51	9.87	6.87	5.37	69.56	53.7	47.11	45.55	36.52	73.26	60.26	49.4	48.57	29.2	36.03
Long-Term Debt/Capital (%)	25.42	12.21	8.53	5.88	34.81	30.18	27.31	26.76	21.35	35.92	30.61	28.67	28.79	18.86	24.24
Long-Term Debt/Total Assets (%)	11.72	6.79	4.99	4.05	33.44	28.47	25.09	23.47	17.89	31.8	27.66	26.94	26.78	17.4	22.34
Total Debt/Equity (%)	16.56	16.38	6.91	5.39	69.61	53.74	47.14	45.55	47.74	73.26	69.38	49.4	49.58	39.66	36.03
Total Debt/Capital (%)	25.5	20.26	8.58	5.91	34.83	30.2	27.32	26.76	27.9	35.92	35.24	28.67	29.39	25.61	24.24
Total Debt/Total Assets (%)	11.76	11.26	5.02	4.08	33.46	28.49	25.11	23.47	23.38	31.8	31.84	26.94	27.34	23.64	22.34
CFO/Total Liabilities	65.88	59.37	72.32	84.04	38.69	42.68	41.17	50.48	50.94	30.36	28.18	12.4	12.84	25.37	19.71
CFO/CapEx	8.31	7.39	0.67	9.31	5.95	6.3	2.32	6.98	10.57	7.67	12.34	5.69	4.97	7.99	9.37
Altman's Z-Score	7.23	8.75	13.47	17.45	7.72	6.95	7.55	6.65	6.04	4.96	4.44	5.13	5.51	5.07	5.27

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	8.49	8.68	9.17	9.17	7.6	6.97	6.04	5.6	5.8	5.6	5.12	4.96	4.64	4.88	5.3
Days Sales Outstanding	43.01	42.06	39.79	39.81	48.05	52.34	60.39	65.18	62.91	65.13	71.28	73.52	78.61	74.86	68.93
Inventory Turnover	1.52	1.41	1.55	1.6	1.46	1.56	1.71	1.98	2.26	1.93	1.74	1.69	1.31	0.93	1.04
Days Inventory Outstanding	240.81	259.02	235.41	228.01	249.74	233.88	213.21	184.14	161.85	189.33	209.35	215.95	278.92	394	351.35
Accounts Payable Turnover	2.89	3.41	5.05	5.86	5.36	5.8	4.53	4.81	4.06	4.2	4.58	4.2	8.31	5.42	4.93
Accounts Payable Turnover Days	126.23	106.99	72.35	62.28	68.15	62.93	80.49	75.83	89.9	86.92	79.64	86.84	43.94	67.31	73.99
Cash Conversion Cycle	157.59	194.1	202.85	205.54	229.63	223.29	193.11	173.49	134.86	167.54	200.99	202.63	313.58	401.54	346.29
Inventory to Cash Days	-197.79	-216.96	-195.63	-188.2	-201.69	-181.54	-152.82	-118.95	-98.94	-124.21	-138.07	-142.44	-200.31	-319.14	-282.42
Inventories	327	447	659	804	893	1,002	903	930	804	1,069	1,352	1,344	2,527	2,460	2,168
Raw Materials	84	102	115	128	- -	- -	- -	- -	170	315	350	413	- -	- -	- -
Work In Process	169	245	435	512	- -	- -	- -	- -	460	544	814	752	- -	- -	- -
Finished Goods	74	101	109	164	- -	- -	- -	- -	174	209	188	200	- -	- -	- -
Other Inventory	- -	- -	- -	- -	893	1,002	903	930	- -	- -	- -	- -	2,527	2,460	2,168

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	19,297	31,887	50,178	75,557	65,074	57,503	68,489	59,812	56,131	39,368	35,960	39,930	37,501	21,871	25,808
- Cash & Cash Equivalents	515	571	603	1,205	1,308	2,326	1,574	1,225	2,914	1,331	2,261	3,419	1,050	2,375	3,008
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	1	2	1	5	2	-12	-15	-8	-4	-14	64	-10	- -	- -	- -
+ Total Debt	1,064	1,141	596	583	6,526	6,517	5,938	5,936	6,368	7,828	7,604	6,614	7,338	6,630	6,577
Enterprise Value	18,672	31,324	49,552	74,300	68,174	59,114	70,723	62,202	58,019	44,572	39,825	41,642	43,789	26,127	28,569
Total Capital	4,172	5,630	6,946	9,872	18,737	21,578	21,734	22,186	22,819	21,790	21,579	23,071	24,966	25,890	27,130
Total Debt/Capital (%)	25.5	20.26	8.58	5.91	34.83	30.2	27.32	26.76	27.9	35.92	35.24	28.67	29.39	25.61	24.24
Total Debt / EV	0.06	0.04	0.01	0.01	0.1	0.11	0.08	0.1	0.11	0.18	0.19	0.16	0.17	0.25	0.23
EV/Sales	3.7	5.68	7.15	7.66	6.33	5.16	5.76	4.62	4.04	3.32	3.63	4.09	4.45	2.7	2.89
EV/EBITDA	8.73	14.21	16.4	16.14	12.14	9.33	10.7	9.35	7.74	9.09	12.08	12.18	18.69	8.85	8.79
EV/EBIT	10.49	17.04	19.9	18.97	13.59	10.45	12.79	10.37	8.25	10.02	14.18	14.35	23.7	11.46	11.57
EV/Cash Flow to Firm	10.66	16.42	20.91	25.07	17.08	12.36	15.11	9.81	8.02	10.11	10.25	26.23	24.76	8.46	11.77
EV/Free Cash Flow to Firm	9.53	14.49	8.43	22.65	14.66	10.73	10.64	8.61	7.34	8.99	9.53	22.75	21.05	7.57	10.73
Diluted Market Cap	19,507	32,129	50,472	75,818	65,215	57,608	68,618	59,929	56,221	39,466	36,081	40,123	37,734	21,916	25,913
Diluted Enterprise Value	20,058	32,701	50,466	75,202	70,435	61,788	72,967	64,633	59,671	45,949	41,486	43,308	44,022	26,172	29,482
EV per Share	77.03	131.65	209.15	314.35	295.51	270.67	332.66	303.57	310.1	277.02	267.1	286.59	302.62	179.44	195.01
TTM Sales	5,049	5,516	6,932	9,703	10,764	11,449	12,274	13,453	14,378	13,445	10,982	10,173	9,836	9,676	9,891
TTM EBITDA	2,139	2,204	3,022	4,605	5,615	6,337	6,610	6,651	7,500	4,904	3,296	3,420	2,342	2,954	3,249
TTM Operating Income	1,780	1,838	2,490	3,917	5,015	5,654	5,529	6,001	7,036	4,446	2,808	2,902	1,848	2,280	2,469
TTM Cash Flow to Firm	1,752	1,907	2,369	2,964	3,992	4,782	4,682	6,340	7,236	4,409	3,886	1,587	1,768	3,090	2,427
TTM Free Cash Flow to Firm	1,960	2,162	5,878	3,280	4,650	5,510	6,644	7,226	7,905	4,960	4,181	1,831	2,080	3,450	2,662

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	10.08	15.05	8.62	23.27	14.25	10.84	10.53	8.47	7.26	8.25	9.17	24.65	20.3	6.77	10.62
EV/EBIT	10.49	17.04	19.9	18.97	13.59	10.45	12.79	10.37	8.25	10.02	14.18	14.35	23.7	11.46	11.57
Enterprise Value	18,672	31,324	49,552	74,300	68,174	59,114	70,723	62,202	58,019	44,572	39,825	41,642	43,789	26,127	28,569
Low Price	56.35	77.8	128.76	207.04	234	204.78	228.83	253.2	216.27	222.41	220.63	188.42	222.02	145.01	108.35
EV/Sales	3.7	5.68	7.15	7.66	6.33	5.16	5.76	4.62	4.04	3.32	3.63	4.09	4.45	2.7	2.89
EV/EBITDA	8.73	14.21	16.4	16.14	12.14	9.33	10.7	9.35	7.74	9.09	12.08	12.18	18.69	8.85	8.79
Price/Earnings	15.63	23.11	26.94	25.75	18.35	15.53	26.97	13.5	9.53	9.84	23.11	13.11	32.3	13.4	19.96
Price/Earnings Average	15.53	20.69	24.6	23.13	21.15	15.23	24.19	14.53	8.39	11.48	27.79	10.94	33.86	18.56	16.03
Price/Earnings High	18.52	24.93	35.18	26.95	29.38	17.78	29.12	17.98	10.84	14.61	40.8	15.02	41.53	23.93	21.01
Price/Earnings Low	11.06	13.41	16.38	16.67	15.22	12.08	19.16	11.71	6.87	8.95	21.14	8.99	27.67	12.94	12.28
Price/Book Value	6.21	7.11	7.9	8.14	5.33	3.82	4.33	3.68	3.41	2.82	2.58	2.42	2.13	1.14	1.26
Price/Book Value Average	6.17	6.36	7.21	7.31	6.14	3.74	3.88	3.96	3	3.29	3.11	2.02	2.23	1.57	1.01
Price/Book Value High	7.36	7.67	10.32	8.52	8.54	4.37	4.68	4.9	3.88	4.18	4.56	2.78	2.74	2.03	1.32
Price/Book Value Low	4.4	4.13	4.8	5.27	4.42	2.97	3.08	3.19	2.46	2.56	2.36	1.66	1.82	1.1	0.77
Price/Tangible Book Value	5.25	7.72	17.22	15.04	24.78	12.36	16.76	14.22	13.85	21.4	12.08	6.9	172.65	40.06	9.98
Price/Tangible Book Value Average	5.22	6.91	15.72	13.51	28.56	12.12	15.03	15.31	12.19	24.97	14.53	5.76	181	55.48	8.01
Price/Tangible Book Value High	6.23	8.33	22.49	15.74	39.68	14.16	18.09	18.95	15.74	31.78	21.33	7.9	222	71.54	10.5
Price/Tangible Book Value Low	3.72	4.48	10.47	9.74	20.56	9.62	11.91	12.34	9.98	19.45	11.05	4.73	147.91	38.68	6.14
Price/Sales	3.82	5.78	7.24	7.79	6.05	5.02	5.58	4.45	3.9	2.93	3.27	3.92	3.81	2.26	2.61
Price/Sales Average	3.8	5.18	6.61	7	6.97	4.92	5	4.79	3.44	3.42	3.94	3.28	4	3.13	2.1
Price/Sales High	4.53	6.24	9.45	8.15	9.68	5.75	6.02	5.92	4.44	4.35	5.78	4.5	4.9	4.04	2.75
Price/Sales Low	2.71	3.36	4.4	5.04	5.02	3.91	3.96	3.86	2.81	2.66	3	2.69	3.27	2.18	1.6
Price/Cash Flow	11.17	16.96	21.4	25.68	16.6	12.54	15.05	9.67	7.93	9.31	9.88	28.85	24.24	7.61	11.71
Price/Cash Flow Average	11.09	15.19	19.53	23.07	19.14	12.29	13.5	10.4	6.98	10.86	11.88	24.07	25.41	10.53	9.4
Price/Cash Flow High	13.23	18.3	27.94	26.88	26.59	14.35	16.24	12.88	9.02	13.82	17.44	33.05	31.17	13.58	12.32
Price/Cash Flow Low	7.91	9.85	13.01	16.63	13.77	9.75	10.69	8.38	5.72	8.46	9.04	19.78	20.76	7.34	7.2
Price/Free Cash Flow Average	10.01	13.48	7.87	20.91	16.42	10.63	9.45	9.12	6.39	9.63	11.03	20.57	21.28	9.38	8.53
Price/Free Cash Flow High	11.94	16.24	11.26	24.36	22.81	12.41	11.37	11.28	8.25	12.26	16.19	28.25	26.11	12.1	11.18
Price/Free Cash Flow Low	7.13	8.74	5.24	15.07	11.82	8.43	7.48	7.35	5.23	7.5	8.39	16.9	17.39	6.54	6.53
EV/Sales Average	3.91	5.28	6.61	6.93	7.45	5.29	5.36	5.14	3.68	3.9	4.43	3.59	4.64	3.57	2.46
EV/Sales High	4.64	6.34	9.45	8.09	10.17	6.12	6.38	6.27	4.68	4.83	6.27	4.81	5.54	4.48	3.11
EV/Sales Low	2.81	3.46	4.4	4.98	5.5	4.27	4.32	4.21	3.05	3.14	3.49	3	3.91	2.62	1.97
EV/EBITDA Average	9.22	13.21	15.16	14.61	14.29	9.56	9.95	10.39	7.05	10.69	14.76	10.67	19.47	11.7	7.48
EV/EBITDA High	10.95	15.87	21.68	17.04	19.49	11.05	11.84	12.69	8.97	13.24	20.91	14.31	23.27	14.66	9.46
EV/EBITDA Low	6.64	8.66	10.09	10.49	10.54	7.72	8.02	8.51	5.85	8.62	11.62	8.94	16.4	8.59	5.98
EV/EBIT Average	11.08	15.84	18.39	17.17	16	10.71	11.9	11.51	7.51	11.79	17.33	12.58	24.68	15.15	9.84
EV/EBIT High	13.16	19.02	26.31	20.03	21.82	12.38	14.16	14.06	9.56	14.61	24.54	16.86	29.5	18.99	12.45
EV/EBIT Low	7.98	10.38	12.25	12.34	11.81	8.65	9.58	9.43	6.24	9.51	13.64	10.53	20.79	11.12	7.87
Last Price	79.61	134.01	211.79	319.67	282.07	263.29	322.15	291.91	300.01	244.67	241.18	274.81	259.16	150.21	176.16
High Price	94.33	144.58	276.55	334.59	451.69	301.47	347.73	388.82	341.1	363.35	425.84	314.89	333.23	268.23	185.38
Enterprise Value Average	19,719	29,127	45,802	67,270	80,229	60,564	65,773	69,084	52,850	52,421	48,654	36,506	45,602	34,544	24,294
Enterprise Value High	23,416	34,974	65,513	78,467	109,426	70,021	78,277	84,373	67,270	64,946	68,898	48,938	54,507	43,310	30,727
Enterprise Value Low	14,210	19,085	30,499	48,319	59,204	48,903	52,998	56,585	43,914	42,268	38,302	30,562	38,414	25,369	19,443

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	242	237	236	235	219	216	212	197	174	152	147	144	145	146	147
Diluted Weighted Avg Shares	245	240	238	237	231	219	213	205	187	161	150	146	146	146	147
Basic Weighted Avg Shares	242	238	237	236	231	218	213	205	187	161	149	145	145	146	146
Revenue per Share	20.83	23.18	29.26	41.05	46.66	52.42	57.73	65.66	76.85	83.56	73.65	70.02	67.97	66.46	67.51
EBITDA per Share	8.82	9.26	12.75	19.48	24.34	29.02	31.09	32.46	40.09	30.48	22.1	23.54	16.19	20.29	22.18
Operating Income per Share	7.34	7.73	10.51	16.57	21.74	25.89	26.01	29.29	37.6	27.63	18.83	19.97	12.77	15.66	16.85
Basic EPS, GAAP	5.09	5.8	7.86	12.42	15.37	16.95	11.94	21.62	31.47	24.86	10.44	20.97	8.02	11.21	8.83
Basic EPS from Cont Ops	5.23	5.8	7.86	12.45	15.58	16.92	12.56	21.84	31.47	25.24	11.59	20.38	8.03	11.21	8.83
Diluted EPS, GAAP	5.04	5.76	7.81	12.37	15.34	16.92	11.92	21.58	31.42	24.8	10.4	20.87	7.97	11.19	8.79
Diluted EPS from Cont Ops	5.17	5.76	7.82	12.4	15.54	16.89	12.54	21.79	31.42	25.17	11.55	20.28	7.98	11.19	8.79
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	7.13	7.9	9.9	12.45	16.99	21	21.41	30.2	37.83	26.29	24.41	9.53	10.69	19.75	15.05
Free Cash Flow per Basic Share	6.27	6.83	-4.91	11.11	14.14	17.67	12.17	25.87	34.25	22.86	22.43	7.85	8.54	17.28	13.44
Cash & Equivalents per Share	6.97	7.17	5.16	7.81	14.86	22.41	17.35	17.27	23.92	16.22	25.5	33.67	7.26	16.31	26.05
Book Value per Share	12.82	18.86	26.8	39.28	52.92	69.01	74.37	79.34	87.95	86.86	93.31	113.33	121.82	132.28	140.29
Tangible Book Value per Share	15.15	17.36	12.3	21.26	11.38	21.3	19.22	20.52	21.67	11.43	19.97	39.84	1.5	3.75	17.66

Biogen Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)